Back
Regulus Therapeutics Stock Price Chart
Sell
35
RGLS
Regulus Therapeutics
Last Price:
1.99
Seasonality Move:
-26.42%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing slight selling pressure.
Regulus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Sell |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.41 | Sell |
| 200-day SMA: | 1.64 | Buy |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.25 | Sell |
| 50-day EMA: | 2.23 | Sell |
| 200-day EMA: | 1.81 | Buy |
Regulus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 37.73 | Sell |
| Chaikin Money Flow: | -87775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.09 - 2.51) | Sell |
| Bollinger Bands (100): | (1.31 - 2.47) | Buy |
Regulus Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regulus Therapeutics Stock
Is Regulus Therapeutics Stock a Buy?
- Regulus Therapeutics share price is 2.00 while RGLS 8-day simple moving average is 2.11, which is a Sell signal.
- The stock price of RGLS is 2.00 while Regulus Therapeutics 20-day SMA is 2.28, which makes it a Sell.
- Regulus Therapeutics 50-day simple moving average is 2.41 while RGLS share price is 2.00, making it a Sell technically.
- RGLS stock price is 2.00 and Regulus Therapeutics 200-day simple moving average is 1.64, creating a Buy signal.
RGLS Technical Analysis vs Fundamental Analysis
Sell
35
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy or a Sell?
-
Regulus Therapeutics stock is rated a Sell
The current Regulus Therapeutics [RGLS] share price is $2.00. The Score for RGLS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Regulus Therapeutics Stock Info
Market Cap:
130.93M
Price in USD:
2.00
Share Volume:
263.32K
Regulus Therapeutics 52-Week Range
52-Week High:
3.79
52-Week Low:
1.08
Sell
35
Regulus Therapeutics (RGLS)
is a Sell
Regulus Therapeutics Share Price Forecast
-
What is the Regulus Therapeutics stock price today?
The Regulus Therapeutics stock price is 2.00 USD today. -
Will RGLS stock go up or go down?
Regulus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Regulus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regulus Therapeutics is overvalued.
Is Regulus Therapeutics Stock a Buy?
- Regulus Therapeutics share price is 2.00 while RGLS 8-day exponential moving average is 2.11, which is a Sell signal.
- The stock price of RGLS is 2.00 while Regulus Therapeutics 20-day EMA is 2.25, which makes it a Sell.
- Regulus Therapeutics 50-day exponential moving average is 2.23 while RGLS share price is 2.00, making it a Sell technically.
- RGLS stock price is 2.00 and Regulus Therapeutics 200-day simple moving average is 1.81, creating a Buy signal.
Fundamental Analysis of Regulus Therapeutics
Is Regulus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.95 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Regulus Therapeutics
Should I short Regulus Therapeutics stock?
- RGLS Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Regulus Therapeutics is a Sell
- Regulus Therapeutics Relative Strength Index (RSI) is 37.73, which suggest Regulus Therapeutics is oversold
- The Bollinger Bands (25) for Regulus Therapeutics is (2.09 - 2.51), which suggest Regulus Therapeutics is a Buy
- The Bollinger Bands (100) for Regulus Therapeutics is (1.31 - 2.47), which suggest Regulus Therapeutics is a Buy
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.